
Aasritha Thippavajjala
PharmD
Aasritha Thippavajjala is a pharm D student and aspiring medical writer with medical writing, clinical training experience and a strong interest in clinical research and patient safety She has hands-on exposure to clinical pharmacy activities including medication profile assessment, clinical case review, identification of potential drug-related problems, ADR awareness, patient counselling, and clinical documentation. She has also gained experience in medical literature review, evidence synthesis, and scientific communication through her published review article on digital twin-based patient simulation and her poster presentation at the 74th Indian Pharmaceutical Congress. Certified in ICH Good Clinical Practice (E6(R3)) and Scientific Writing in Health Research, she is passionate about applying her clinical knowledge and research skills to medical writing,clinical research and contributing to accurate, evidence-based healthcare.
About Aasritha
Aasritha Thippavajjala (PharmD) is a writer at Pharmacally, with 41 published articles, each checked against primary sources by our editorial team.
Articles by Aasritha Thippavajjala
Clinical TrialsRoche Secures Positive CHMP Recommendation for Obinutuzumab in SLE
Clinical TrialsLilly’s Taltz-Zepbound Combination Delivers 43.7% ACR50 Response
Clinical TrialsLilly’s Foundayo Improves OSA Severity in PAP and Non-PAP Users
Clinical TrialsObsidian’s Amsoki-cel Shows 67% ORR in ICI-Resistant Melanoma
Clinical TrialsADC Highlights Strong ZYNLONTA Responses Across Three Trials
Clinical TrialsHoth Ends HT-001 Phase 2a Early, Plans FDA Talks on Potential Phase 3
Clinical TrialsTeva to Stop TOPAS-MSA Trial After Interim Futility Finding
Clinical TrialsRegeneron’s Libtayo Maintains DFS Benefit in Longer-Term C-POST Results
Clinical TrialsaTyr’s Efzofitimod Shows Mixed Results in Sarcoidosis
A. Musharaf Mohammad
Aabha Dey